PURE - PURE Bioscience, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 542.54M
Enterprise Value 344.97M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)24.62
Price/Book (mrq)13.02
Enterprise Value/Revenue 326.02
Enterprise Value/EBITDA 6-6.80

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2017
Most Recent Quarter (mrq)Jan 31, 2018


Profit Margin 0.00%
Operating Margin (ttm)-399.42%

Management Effectiveness

Return on Assets (ttm)-85.58%
Return on Equity (ttm)-221.54%

Income Statement

Revenue (ttm)1.73M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)-8.10%
Gross Profit (ttm)1.07M
Net Income Avi to Common (ttm)-7.95M
Diluted EPS (ttm)-0.123
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.13M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.99
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-4.46M
Levered Free Cash Flow (ttm)-3.28M

Trading Information

Stock Price History

Beta -1.05
52-Week Change 3-29.55%
S&P500 52-Week Change 313.44%
52 Week High 31.360
52 Week Low 30.000
50-Day Moving Average 30.693
200-Day Moving Average 30.901

Share Statistics

Avg Vol (3 month) 339.91k
Avg Vol (10 day) 315.18k
Shares Outstanding 568.06M
Float 43.57M
% Held by Insiders 136.66%
% Held by Institutions 10.49%
Shares Short 3222.97k
Short Ratio 32.56
Short % of Float 32.08%
Shares Short (prior month) 3226.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/8
Last Split Date 3Aug 15, 2012